市場調查報告書

全球神經修復及再生市場 - 各產品類型、應用領域、終端用戶、地區 - 成長,趨勢,預測(2018年∼2023年)

Global Nerve Repair and Regeneration Market - Segmented by Product Type, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 661044
出版日期 內容資訊 英文 105 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球神經修復及再生市場 - 各產品類型、應用領域、終端用戶、地區 - 成長,趨勢,預測(2018年∼2023年) Global Nerve Repair and Regeneration Market - Segmented by Product Type, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)
出版日期: 2018年05月15日內容資訊: 英文 105 Pages
簡介

全球神經修復及再生市場,預計從2018年到2023年以約11.7%的年複合成長率發展。跨國大企業的強力產品平台的存在,和對神經疾病的治療效果提高,成為這個市場的主要成長要素。各地區中,預計整備醫療基礎設施與健康保險制度,神經疾病的罹患率高的北美地區在調查期間中獨占佔有率。

本報告提供全球神經修復及再生市場調查,市場概要,各產品類型、應用領域、終端用戶、地區的市場規模的變化與預測,市場趨勢,成長要素、阻礙因素以及市場機會、課題分析,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 市場動態

  • 市場成長要素
    • 老年人的神經疾病及末梢神經病變的盛行率上升
    • 神經修復、再生技術的進步
    • 對已開發國家的醫療費的增加與市場方便的政策方針
  • 市場阻礙因素
    • 神經刺激/神經調節設備的成本高
    • 專家的不足
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各產品類型
    • 神經刺激/神經調節設備
    • 生物材料
  • 各應用領域
    • 神經刺激/神經調節手術
    • 直接性神經修復、神經縫合術
    • 神經移植術
    • 幹細胞療法
  • 各終端用戶
    • 醫院、診療所
    • 門診外科中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • M&A分析
  • 協定,合作,夥伴關係
  • 新產品的銷售

第9章 主要企業

  • Abbott
  • AxoGen Inc.
  • Baxter
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Medtronic Plc
  • Nuvectra
  • OrthoMed, Inc.
  • Polyganics
  • Stryker
  • 其他企業

第10章 市場未來展望

目錄
Product Code: 60471

The global nerve repair and regeneration market is expected to register a growth rate of approximately 11.7% during the forecast period (2018-2023). The presence of strong product pipeline of major multinational companies and improved treatment efficiency for neurological disorders are some of the primary drivers for this market. North America is anticipated to dominate the market share during the forecast period owing to well-developed healthcare infrastructure, better health insurance policies, and higher incidence rate of neural disorders.

Rising Prevalence of Neurological Diseases and Peripheral Nerve Injuries in Geriatric Population

The global rising prevalence of neurological diseases and peripheral nerve injuries in geriatric population is one of the primary factors driving this market. Some of the most common neurological disorders include stroke, migraine, brain tumors, spinal cord injuries, and multiple sclerosis, among others. The peripheral nerve injuries also occur at a rising incidence rate, with the presence of traumatic neuropathies and neuropathic pain, including crush injuries. Around 500,000 deaths by brain aneurysms have been recorded worldwide each year. Thus, in the forecast period, this number is further expected to grow each year, creating the need for more nerve repair and regeneration products.

Other factors driving this market are technological advancements in nerve repair and regeneration with rise in the healthcare expenditure by government with favorable policies in developed market.

High Cost of Neurostimulation and Neuromodulation Devices

The expensive nature of neurostimulation and neuromodulation devices is one of the key factors restricting the growth of this market. Due to this, they are not widely used, costing anywhere from several hundred dollars to tens of thousands of dollars. Moreover, the insurance companies cover costs for some therapies but not all. This affects the hospital's overall budget; for example, in 2015, according to Modern Healthcare, hospitals faced the higher prices issues for spinal cord stimulators by companies such as Boston Scientific and Medtronic. Thus, this factor would play a significant role in hindering this market.

United States is the Largest Market

In North America, the presence of multinational companies with continuous technological developments with rising availability of medical devices, favorable insurance policies, and increasing incidence rate of neural disorders drive the market, particularly in the United States. Availability of technologically advanced devices by major companies such as Medtronic and Boston Scientific helps in the dominance of this market in the country.

Key Developments in the Market:

January 2018 - Orthocell Limited received Australian patent for its CelGro collagen medical device platform, which covers the method of suture-less repair of soft tissue defects.

November 2017 - AxoGen, Inc. expands its platform for nerve repair to address breast reconstruction neurotization following mastectomy.

Major player: ABBOTT, AXOGEN INC., BAXTER, BOSTON SCIENTIFIC CORPORATION, CYBERONICS, INC, MEDTRONIC PLC, NUVECTRA, ORTHOMED, INC., POLYGANICS, AND STRYKER, amongst others.

Reasons to Purchase the Report:

Current and future global nerve repair and regeneration market in the developed and emerging markets

Analysis of various perspectives of the market with the help of Porter's five forces analysis

The segment that is expected to dominate the market

Regions that are expected to witness the fastest growth during the forecast period

Identify the latest developments, market shares, and strategies employed by the major market players

3 month analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Report:

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitute Product and Services
    • 5.2.5 Competitive Rivalry within the Industry

6. Market Dynamics

  • 6.1 Market Drivers
    • 6.1.1 Rising Prevalence of Neurological Diseases and Peripheral Nerve Injuries in Geraitric Population
    • 6.1.2 Technological Advancements for Nerver Repair and Regeneration
    • 6.1.3 Rise in Healthcare Expenditure by Government with Favourable Policies in Developed Market
  • 6.2 Market Restraints
    • 6.2.1 High Cost Associated with Neurostimulation and Neuromodulation Devices
    • 6.2.2 Dearth of Trained Professionals
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 By Product Type
    • 7.1.1 Neurostimulation and Neuromodulation Devices
      • 7.1.1.1 Internal Neurostimulation Devices
      • 7.1.1.1.1 Spinal Cord Stimulation (SCS)
      • 7.1.1.1.2 Deep Brain Stimulation (DBS)
      • 7.1.1.1.3 Vagus Nerve Stimulation (VNS)
      • 7.1.1.1.4 Sacral Nerve Stimulation (SNS)
      • 7.1.1.1.5 Gastric Electrical Stimulation (GES)
      • 7.1.1.1.6 Others
      • 7.1.1.2 External Neurostimulation Devices
      • 7.1.1.2.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 7.1.1.2.2 Transcranial Magnetic Stimulation (TMS)
    • 7.1.2 Biomaterials
      • 7.1.2.1 Nerve Conduits
      • 7.1.2.2 Nerve Protectors
      • 7.1.2.3 Nerve Wraps
      • 7.1.2.4 Nerve Connectors
  • 7.2 By Application
    • 7.2.1 Neurostimulation and Neuromodulation Surgeries
    • 7.2.2 Direct Nerve Repair/Neurorrhaphy
    • 7.2.3 Nerve Grafting
    • 7.2.4 Stem Cell Therapy
  • 7.3 By End User
    • 7.3.1 Hospitals & Clinics
    • 7.3.2 Ambulatory Surgery Centers
    • 7.3.3 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States
      • 7.4.1.2 Canada
      • 7.4.1.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 France
      • 7.4.2.2 Germany
      • 7.4.2.3 United Kingdom
      • 7.4.2.4 Italy
      • 7.4.2.5 Spain
      • 7.4.2.6 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China
      • 7.4.3.2 Japan
      • 7.4.3.3 India
      • 7.4.3.4 Australia & New Zealand
      • 7.4.3.5 South Korea
      • 7.4.3.6 Rest of Asia-Pacific
    • 7.4.4 Middle East & Africa
      • 7.4.4.1 GCC
      • 7.4.4.2 South Africa
      • 7.4.4.3 Rest of the Middle East & Africa
    • 7.4.5 South America
      • 7.4.5.1 Brazil
      • 7.4.5.2 Argentina
      • 7.4.5.3 Rest of South America

8. Competitive Landscape

  • 8.1 Mergers & Acquisition Analysis
  • 8.2 Agreements, Collaborations, and Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 Abbott
  • 9.2 AxoGen Inc.
  • 9.3 Baxter
  • 9.4 Boston Scientific Corporation
  • 9.5 Cyberonics, Inc.
  • 9.6 Medtronic Plc
  • 9.7 Nuvectra
  • 9.8 OrthoMed, Inc.
  • 9.9 Polyganics
  • 9.10 Stryker
  • 9.11 List Not Exhaustive

10. Future of the Market

Back to Top